The prognostic and predictive values of circulating HER-2/neu extracellular domain in patients with metastatic breast cancer

Breast Cancer Res Treat. 2009 Apr;114(3):513-5. doi: 10.1007/s10549-008-0145-8. Epub 2008 Aug 2.
No abstract available

Publication types

  • Comment

MeSH terms

  • Biomarkers, Tumor / blood
  • Breast Neoplasms / blood*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / mortality*
  • Clinical Trials as Topic
  • Disease-Free Survival
  • Female
  • Humans
  • Neoplasm Metastasis
  • Predictive Value of Tests
  • Prognosis
  • Receptor, ErbB-2 / blood*
  • Receptor, ErbB-2 / chemistry*
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • Receptor, ErbB-2